ArticleCPT: pharmacometrics & systems pharmacology2023

PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticaria.

Elise Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.